Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.32
22.04.23
-
22.04.24
127.27%
23.04.24

StockNews.com 
22.04.23 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.51
22.04.23
-
22.04.24
-66.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
22.04.23
-
22.04.24
-
23.04.24

StockNews.com 
22.04.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.95
22.04.23
-
22.04.24
-27.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.91
22.04.23
-
22.04.24
-52.75%
23.04.24

StockNews.com 
22.04.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.40
20.04.23
-
20.04.24
205.00%
21.04.24

Robert W. Baird 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€111.01
20.04.24
-0.75%
21.04.24

JPMorgan Chase & Co. 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€121.02
20.04.24
-0.75%
21.04.24

Sanford C. Bernstein 
20.04.23 50%
sell
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€93.72
20.04.24
-0.75%
21.04.24

Wolfe Research 
20.04.23 50%
sell
SCYNEXIS Inc.

Start price
Target price
Perf. (%)
€2.86
20.04.23
-
20.04.24
-4.38%
24.04.23

Probably not worthwhile Investment
Lokrim 
20.04.23 20%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€9.11
20.04.24
-38.50%
21.04.24

Evercore ISI 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€102.04
20.04.23
€118.42
20.04.24
-1.53%
21.04.24

UBS Group AG 
20.04.23 50%
buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€10.70
20.04.23
€20.50
20.04.24
29.91%
21.04.24

EF Hutton Acquisition Co. I 
20.04.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€12.77
20.04.24
-38.50%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€41.00
20.04.23
€54.71
20.04.24
-40.98%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€4.61
20.04.23
€8.20
20.04.24
81.37%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.73
20.04.23
€16.39
20.04.24
39.05%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€2.04
20.04.23
€14.57
20.04.24
15.23%
21.04.24

HC Wainwright 
20.04.23 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
20.04.23
€14.57
20.04.24
-69.78%
21.04.24

HC Wainwright 
20.04.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€56.40
20.04.23
€60.11
20.04.24
22.34%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.74
20.04.23
€14.57
20.04.24
-44.59%
21.04.24

Roth Mkm 
20.04.23 50%
buy
Exact Sciences

Start price
Target price
Perf. (%)
€62.80
20.04.23
€65.50
03.05.24
9.71%
27.12.23

Solomon 
20.04.23 90%
buy
Agenus Inc.

Start price
Target price
Perf. (%)
€1.60
19.04.23
€1.00
19.04.24
-14.58%
01.05.23

Innovative
overvalued
Risky Investment
High risks for its business
ReynadJ 
19.04.23 100%